CLINICAL_TRIALS
trial_result
· 2008-10-20
Clinical Trial Update: Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 trial of androgen therapy for ER-/PR- metastatic breast cancer was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Legacy Health System | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED